Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Curious

<< Previous

Bullboard Posts

Next >>

Comment by consultant99on Mar 21, 2023 4:38pm

226 Views

Post# 35352204

RE:RE:RE:Curious

I could think of a few lol:

Has the company applied for BTD?

What were the terms of the agreement signed in July for the vaccine study currently underway?

Does the company expect to apply for AA in 2023 or later?

Was the adding of additional sites for the phase 2 trial to complete the trial faster or were there other reasons?

The last corporate update was June 2022 - why is the company not updating it when it becomes outdated?

What is the status of research on brain and lung cancer and when will the phase 1 trials start?

I am sure there a million more lol

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments